Tempus Stock

Precision Medicine Solutions

Sign up today and learn more about Tempus Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

New Enterprise Associates


Chicago IL, US

Total Funding


About Tempus Stock

Tempus is a technology-enabled precision medicine solutions company that has built an operating system to battle cancer. It is on a mission to redefine how genomic data is used in a clinical setting. Their goal is for each patient to benefit from the treatment of others who came before by enabling physicians to deliver personalized cancer care for patients through interactive analytical and machine learning platform. Eric Lefkofsky founded it in 2015 and is headquartered in Chicago, Illinois.


Funding History

September 2015$10.0M
June 2016$10.0M
November 2016$10.0M
April 2017$30.0M
September 2017$70.0M
March 2018$80.0M
August 2018$111M
April 2019$200M
February 2020$97.3M
November 2020$409M


Chief Executive Officer

Eric Lefkofsky

Chief Financial Officer

Jim Rogers

Chief Technology Officer

Shane Colley


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: